Pigmentation

Melanotan II Guide

A commonly searched analog where safety, legality, and informal use claims require especially careful review before publication.

By
PD Team
Published
May 23, 2026
Last updated
May 23, 2026
Read time
10 min read
Citations
8 citations
Review
Editorially reviewed by PD Team

Profile snapshot

Quick facts

These fields are educational context only. Typical dose information is not dosing guidance.

Type
Unapproved melanocortin analog
Half-life
Not established in regulated labeling
Typical dose
No FDA-approved dose; informal use claims require safety review.
Regulatory status
Not an FDA-approved medication

Current status

Melanotan II is not an FDA-approved medicine. As of May 23, 2026, regulator materials from FDA, TGA, and HPRA describe Melanotan II or Melanotan 2 products as unapproved, unauthorized, or illegally supplied when marketed for tanning or consumer use.

Plain-English summary

Overview

Melanotan II, often shortened online to MT-II or MT2, is a synthetic melanocortin peptide most commonly discussed in connection with tanning products, libido effects, and internet "research chemical" markets. Regulators describe these products as unapproved or unauthorized when promoted for consumer tanning use. [1][2][4]

The core reason Melanotan II attracts attention is that melanotans can increase melanin production in the skin, creating a darker appearance. That does not mean the product is safe, approved, sterile, or protective against ultraviolet radiation. [2][6]

This profile is educational. It does not provide dosing, reconstitution, injection, nasal-spray, sourcing, or purchase guidance. The practical takeaway is that Melanotan II is a biologically active, systemically acting peptide with limited human data and repeated regulator warnings. [1][2][4]

  • Common names: Melanotan II, Melanotan 2, MT-II, MT2. [2][4]
  • Common online context: tanning injections, nasal sprays, drops, and other unapproved products. [2][4]
  • Regulatory status: not FDA-approved; not authorized by HPRA or any medicines regulator for treating conditions; not approved for sale or use as a tanning agent in Australia. [1][2][4]

Melanocortin biology

Mechanism / Melanocortin Context

Melanotan II is usually described as an alpha-melanocyte-stimulating hormone analog. In skin, melanocortin signaling can increase melanin production, which explains why it is promoted as a tanning peptide. [2][5]

The biology is broader than skin pigmentation. A human-study review describes Melanotan II as a non-selective melanocortin receptor agonist, and melanocortin receptors are involved in central nervous system pathways related to penile erection and sexual motivation. [5][7]

That broad receptor activity helps explain why reported effects are not limited to skin darkening. Early human studies and regulator warnings mention nausea, yawning, flushing, appetite effects, and spontaneous erections, which are systemic effects rather than cosmetic-only effects. [2][5][7][8]

A darker tan should not be interpreted as meaningful sun protection. TGA states that melanotan-induced pigmentation will not protect against UV exposure like suitable sunscreen, and FDA notes that tanning remains associated with skin-cancer and skin-aging risks even when a person does not burn. [2][6]

Small studies, no approval pathway

Evidence / Human Data and Lack of Approval

The human evidence base is small and old compared with approved medicines. A pilot Phase 1 study in three normal male volunteers reported dose-related pharmacodynamic effects such as mild nausea, stretching and yawning, and intermittent spontaneous penile erections after Melanotan II dosing. [8]

A later review of human studies in men with erectile dysfunction described a double-blind, placebo-controlled crossover design in 20 men. In that setting, Melanotan II initiated erections in many participants and increased reported sexual desire more often than placebo, but nausea and yawning were frequent side effects. [7]

Those studies do not establish Melanotan II as a safe consumer tanning product, a long-term cosmetic product, or a general sexual-function therapy. They were limited research contexts, not approved product labels or large modern outcomes programs. [1][4][7][8]

FDA regulatory records describe Melanotan II as an unapproved new drug when marketed by Melanocorp as an injectable tanning product. In Australia, TGA stated in May 2026 that there were no products containing Melanotan II on the Australian Register of Therapeutic Goods or approved for supply in Australia. [1][3]

  • What exists: small early human studies focused mainly on pharmacodynamic effects and erectile-function endpoints. [7][8]
  • What is missing: robust long-term safety data for repeated consumer tanning use, nasal sprays, online vials, or unsupervised cosmetic use. [2][4]

Marketing claims vs evidence

Claimed Benefits vs Evidence

Tanning claims are mechanistically plausible because melanotans can increase melanin production, but regulators warn that tanning products containing melanotan are being illegally promoted and sold online, have not been assessed for quality or safety, and may contain poor-quality, counterfeit, or toxic ingredients. [2]

Claims that Melanotan II protects against skin cancer should be treated as especially unreliable. FDA records describe prior marketing claims that Melanotan II could reduce skin cancer rates, while FDA identified the product as an unapproved drug sold without an approved application. TGA warns that the most concerning risk is serious skin cancers and that melanotan does not replace sunscreen. [1][2]

Libido and erectile-function claims come from melanocortin biology and small human studies, but those findings are not the same thing as approval, long-term safety, or a treatment recommendation. Side effects in those same studies were common enough to matter when interpreting the signal. [5][7][8]

Claims about appetite suppression, body composition, "sunless protection," or skin-health optimization are not supported here as proven consumer benefits. They should be separated from actual evidence and from regulator warnings about unapproved products. [2][4][6]

Regulator warnings and real-world concerns

Safety Context

TGA warns that common side effects of melanotan products include headache, nausea, vomiting, loss of appetite, and facial redness. It also reports more serious concerns with Melanotan II, including increased moles and freckles, kidney dysfunction, and swelling of the brain. [2]

HPRA describes Melanotan 2 as an unregulated substance that is not safe for use and may cause serious, long-term harm. HPRA lists serious side effects including new moles, darkening of existing moles and freckles, potential loss of vision, muscle tremors, stroke, and anaphylaxis. [4]

Unapproved product quality is a separate safety issue. TGA states that because these tanning products are not approved for sale or use, consumers have no reliable way to know what is in them, regardless of the label. FDA records around Melanocorp also described products marketed as U.S.-made when some material had been imported from China. [1][2]

Route matters. Injected, inhaled, or ingested products raise different risks from topical cosmetic bronzers, especially when sterility, concentration, identity, and handling are unknown. HPRA specifically notes that products sold as injectable powders, drops, or nasal sprays act within the body and should not be treated as ordinary cosmetics. [4]

No approved consumer label

Storage and Handling Limits

There is no FDA-approved Melanotan II product label that can be used as a reliable public storage standard. Without an approved product, validated manufacturing controls, and official labeling, storage claims from sellers should not be treated as proof of quality, sterility, or suitability for human use. [1][2][4]

This profile intentionally does not provide reconstitution steps, injection technique, nasal-spray handling, storage duration, or transport conditions. Those details would turn an educational profile into unsafe use guidance for an unapproved product category. [1][2][4]

For legitimate medicines, handling instructions come from official labeling, authorized clinical-trial protocols, or qualified healthcare professionals. Melanotan II products sold online for tanning do not provide that same regulatory assurance. [1][2][4]

FAQ

Is Melanotan II FDA-approved?

No. FDA regulatory records describe Melanotan II as an unapproved new drug when marketed as an injectable tanning product, and this profile did not identify any FDA-approved Melanotan II product as of May 23, 2026. [1]

Is Melanotan II approved for tanning?

No. TGA says Melanotan II is not approved for sale or use as a tanning agent in Australia, and HPRA says Melanotan 2 is not authorized by HPRA or any medicines regulator to treat any condition, including changing skin colour. [2][3][4]

Does Melanotan II protect against sun damage?

No reliable public-health source supports using Melanotan II as sun protection. TGA specifically says artificially increased pigmentation from melanotan will not protect against UV exposure like suitable sunscreen, and FDA warns that tanning exposure can still increase skin-cancer and skin-aging risk. [2][6]

Why do people report libido or erection effects?

Melanotan II is a melanocortin receptor agonist with central nervous system effects. Small human studies in men reported erection and sexual-desire effects, but also frequent nausea and yawning. That is not the same as approval or long-term safety. [5][7][8]

Are nasal sprays safer than injections?

Do not assume that. HPRA and TGA warnings cover multiple forms, including nasal sprays, drops, injectable powders, tablets, creams, and other products. Product identity, quality, route, and systemic exposure remain concerns. [2][3][4]

Can this page provide storage, reconstitution, or dosing instructions?

No. This site does not provide dosing protocols, reconstitution steps, injection instructions, nasal-spray instructions, or purchase guidance for Melanotan II. [1][2][4]

References

  1. [1] Notice of Opportunity for Hearing: Manookian, Edward

    U.S. Food and Drug Administration. August 5, 2016.

    https://www.fda.gov/regulatory-information/electronic-reading-room/notice-opportunity-hearing-nooh-manookian-edward-8516
  2. [2] Don't risk using tanning products containing melanotan

    Therapeutic Goods Administration. January 24, 2025; accessed May 23, 2026.

    https://www.tga.gov.au/news/blog/dont-risk-using-tanning-products-containing-melanotan
  3. [3] Individual issued 27 infringement notices for allegedly supplying Melanotan II

    Therapeutic Goods Administration. May 2026; accessed May 23, 2026.

    https://www.tga.gov.au/news/media-releases/individual-issued-27-infringement-notices-allegedly-supplying-melanotan-ii
  4. [4] Reminder of serious health risks with Melanotan 2 self-tan products

    Health Products Regulatory Authority. August 10, 2023; accessed May 23, 2026.

    https://www.hpra.ie/safety-information/safety-notices/article/reminder-of-serious-health-risks-with-melanotan-2-self-tan-products
  5. [5] Melanocortin Receptors, Melanotropic Peptides and Penile Erection

    Current Topics in Medicinal Chemistry / PMC. 2007.

    https://pmc.ncbi.nlm.nih.gov/articles/PMC2694735/
  6. [6] Tanning Products

    U.S. Food and Drug Administration. Current FDA consumer information; accessed May 23, 2026.

    https://www.fda.gov/radiation-emitting-products/tanning/tanning-products
  7. [7] Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II

    International Journal of Impotence Research / PubMed. October 2000.

    https://pubmed.ncbi.nlm.nih.gov/11035391/
  8. [8] Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

    Life Sciences / PubMed. May 24, 1996.

    https://pubmed.ncbi.nlm.nih.gov/8637402/